CME Group Inc. (NASDAQ: CME) is a Financial Services company in the Financial - Data & Stock Exchanges industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 23.30 | EPS (ttm) | 11.79 | Insider Own | 0.34% | Shs Outstand | 359.58M | Perf Week | -4.10% |
| Market Cap | 98.78B | Forward P/E | 21.27 | EPS next Y | 12.91 | Insider Trans | -4.18% | Shs Float | 354.62M | Perf Month | 4.19% |
| Enterprise Value | 99.92B | PEG | 3.34 | EPS next Q | 2.96 | Inst Own | 86.24% | Short Float | 1.47% | Perf Quarter | 7.33% |
| Income | 4.27B | P/S | 14.58 | EPS this Y | 3.93% | Inst Trans | 0.00% | Short Ratio | 1.60 | Perf Half Y | -10.33% |
| Sales | 6.77B | P/B | 3.72 | EPS next Y | 5.38% | ROA | 2.19% | Short Interest | 5.20M | Perf YTD | 0.59% |
| Book/sh | 73.75 | P/C | 43.40 | EPS next 5Y | 6.98% | ROE | 15.53% | 52W High | 329.18 -16.55% | Perf Year | 4.62% |
| Cash/sh | 6.33 | P/FCF | 24.01 | EPS past 3/5Y | 14.68% 13.71% | ROIC | 9.38% | 52W Low | 218.31 25.83% | Perf 3Y | 35.39% |
| Dividend Est. | 5.20 (1.89%) | EV/EBITDA | 18.62 | Sales past 3/5Y | 9.12% 5.95% | Gross Margin | 81.89% | Volatility | 1.83% 2.00% | Perf 5Y | 36.18% |
| Dividend TTM | 11.30 (4.11%) | EV/Sales | 14.75 | EPS Y/Y TTM | 21.92% | Oper. Margin | 65.10% | ATR (14) | 5.86 | Perf 10Y | 155.89% |
| Dividend Ex-Date | Sep 09, 2026 | Quick Ratio | 1.02 | Sales Y/Y TTM | 10.49% | Profit Margin | 63.08% | RSI (14) | 51.97 | Recom | 2.76 |
| Dividend Gr. 3/5Y | -16.21% -3.26% | Current Ratio | 1.02 | EPS Q/Q | 1.01% | SMA20 | -0.50% | Beta | 0.27 | Target Price | 299.00 |
| Payout | 95.41% | Debt/Eq | 0.13 | Sales Q/Q | 0.83% | SMA50 | 5.37% | Rel Volume | 0.57 | Prev Close | 278.23 |
| Employees | 3,875 | LT Debt/Eq | 0.13 | Earnings | Oct 21 | SMA200 | -1.47% | Avg Volume | 2.81M | Price | 274.70 |
| IPO Date | Dec 06, 2002 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.92% 1.43% | Net Debt/EBITDA | 0.24 | Volume | 1,599,581 | Change | -1.27% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-19-26 | Downgrade | Deutsche Bank | Buy → Hold | $300 → $270 |
| Jul-23-26 | Reiterated | Morgan Stanley | Overweight | $324 → $330 |
| Jul-15-26 | Reiterated | Piper Sandler | Overweight | $320 → $295 |
| Jul-10-26 | Reiterated | Morgan Stanley | Overweight | $353 → $324 |
| Jul-06-26 | Reiterated | UBS | Neutral | $310 → $260 |
| Jun-18-26 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform | |
| Jun-17-26 | Reiterated | Piper Sandler | Overweight | $329 → $320 |
| Jun-15-26 | Reiterated | Piper Sandler | Overweight | $225 → $329 |
| Jun-11-26 | Reiterated | Redburn Partners | $323 | |
| Jun-11-26 | Upgrade | Rothschild & Co | Neutral → Buy |
CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,773 | 6,521 | 6,130 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,227 | 907 | 850 | — | — | — | — | — | — | |
| Gross Profit | 5,547 | 5,614 | 5,280 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 142 | 151 | 133 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 994 | 1,233 | 1,215 | — | — | — | — | — | — | |
| Operating Income | 4,410 | 4,230 | 3,932 | — | — | — | — | — | — | |
| Interest Expense | 88 | 130 | 161 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1,273 | 1,231 | 771 | — | — | — | — | — | — | |
| Net Income Before Taxes | 5,594 | 5,331 | 4,541 | — | — | — | — | — | — | |
| Income Taxes | 1,322 | 1,273 | 1,016 | — | — | — | — | — | — | |
| Consolidated Net Income | 4,272 | 4,044 | 3,526 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 4,272 | 4,057 | 3,526 | — | — | — | — | — | — | |
| Net Income | 4,272 | 4,044 | 3,526 | — | — | — | — | — | — | |
| EPS (Recurring) | 11.85 | 11.18 | 9.69 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 11.85 | 11.18 | 9.69 | — | — | — | — | — | — | |
| EPS (Diluted) | 11.79 | 11.16 | 9.67 | — | — | — | — | — | — | |
| EBITDA | 5,366 | 5,720 | 5,039 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 23.30 | 24.47 | 24.02 | — | — | — | — | — | — | |
| Price To Sales Ratio | 14.60 | 15.08 | 13.60 | — | — | — | — | — | — | |
| Gross Margin | 81.90 | 86.09 | 86.13 | — | — | — | — | — | — | |
| Operating Margin | 65.11 | 64.87 | 64.14 | — | — | — | — | — | — | |
| Net Margin | 63.07 | 62.02 | 57.52 | — | — | — | — | — | — | |
| Shares Outstanding | 360 | 360 | 359 | — | — | — | — | — | — | |
| Market Capitalization | 98,892 | 98,309 | 83,371 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SHEPARD WILLIAM R | Director | Jun 25 '26 | Buy | 230.57 | 339 | 78,186 | 260,442 | Jun 29 |
| Piell Hilda Harris | Sr MD & Chief HR Officer | May 18 '26 | Sale | 304.63 | 5,753 | 1,752,536 | 27,702 | May 19 |
| DUFFY TERRENCE A | Chairman and CEO | May 15 '26 | Sale | 298.51 | 35,000 | 10,447,865 | 55,630 | May 18 |
| SHEPARD WILLIAM R | Director | Mar 26 '26 | Buy | 297.38 | 1,470 | 437,101 | 260,118 | Mar 30 |
| Marcus Jonathan L | Sr MD General Counsel | Mar 17 '26 | Sale | 323.37 | 6,582 | 2,128,422 | 7,192 | Mar 23 |
| Vroman Ken | Chief Transformation Officer | Mar 12 '26 | Sale | 309.00 | 5,160 | 1,594,440 | 14,910 | Mar 12 |
| Cook Elizabeth A | Director | Mar 06 '26 | Sale | 320.00 | 1,000 | 320,000 | 17,771 | Mar 09 |
| Durkin Bryan T | Director | Feb 23 '26 | Sale | 309.65 | 4,200 | 1,300,530 | 43,007 | Feb 23 |
| GEPSMAN MARTIN J | Director | Feb 20 '26 | Sale | 305.90 | 300 | 91,770 | 24,999 | Feb 20 |
| Suskind Dennis | Director | Feb 06 '26 | Sale | 300.00 | 748 | 224,400 | 2,699 | Feb 09 |
| SHEPARD WILLIAM R | Director | Dec 30 '25 | Buy | 278.37 | 262 | 73,008 | 258,710 | Jan 02 |
| DUFFY TERRENCE A | Chairman and CEO | Dec 11 '25 | Sale | 269.55 | 25,000 | 6,738,816 | 65,804 | Dec 15 |
| Sammann Derek | Sr MD Gl Hd Commodities Mkts | Nov 20 '25 | Sale | 275.67 | 7,200 | 1,984,798 | 7,022 | Nov 21 |
| Ford Harold Eugene Jr. | Director | Nov 03 '25 | Sale | 263.53 | 1,000 | 263,530 | 1,091 | Nov 04 |
| SHEPARD WILLIAM R | Director | Sep 25 '25 | Buy | 265.19 | 274 | 72,672 | 258,459 | Sep 26 |